15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

Back to Agenda

[V4-S6] Possibility of AI for Future New Drug Evaluation and Review Process

Session Chair(s)

Makoto Suzuki, PhD

Director, Medical Writing

MSD K.K., Japan

Share what next innovation technology is available in global drug development, such as AI translation in the medical field using multi-language speech translation technology of Ministry of Internal Affairs and Communications, and discuss shortening of approval review period using innovation such as AI.

Speaker(s)

High Quality Automatic Translation By Using AI

Eiichiro Sumita, PhD

National Institute of Information and Communications Technology (NICT), Japan

NICT Fellow, Associate Director General of ASTREC

Development and Influence of Digital Technonlogy

Kazuya Obanayama

Bayer Yakuhin, Ltd., Japan

Digital Transformation Product Leader & PMO, Commercial Operations Management

Creation of Package Inserts Post-Marketing Materials Using XML

Megumi Sato